Latest Derivatives News

Insurance Australia Group Limited has declared a quarterly distribution of AUD 1.5069 per Capital Note, reflecting a 6.04% annualised yield, payable mid-December 2025.

Northern Minerals has released its Definitive Feasibility Study for the Browns Range Heavy Rare Earth Project, confirming an 11-year production plan targeting 181,000 tonnes of rare earth concentrate. The project aims to establish a critical Australian supply chain for heavy rare earths in partnership with Iluka Resources.

BPH Global has completed an 18-week R&D collaboration with Singapore Polytechnic, developing two innovative green seaweed kefir beverages that combine health benefits with commercial promise.

Superior Resources reports exceptional copper-gold-silver assay results up to 46.5% Cu from its Greenvale Project, confirming Halls Reward and Telegraph as priority high-grade targets. Follow-up exploration is set to unlock further potential.

Litchfield Minerals reports assays confirming up to 35% manganese with a hydrothermal signature at Lucy Creek 2, Northern Territory, signaling a potentially larger manganese system. Planned geophysical surveys and drilling in 2026 aim to unlock further resource potential.

29Metals Limited reports promising high-grade copper and zinc drill results from its 2025 exploration program at Golden Grove, highlighting potential mine life extensions and resource growth opportunities.

Proteomics International has unveiled new clinical data confirming its PromarkerEso blood test can accurately detect early stages of esophageal adenocarcinoma, potentially transforming screening for a cancer with poor prognosis.

Cambium Bio has secured a strategic partnership with French pharmaceutical leader Benta SAS to commercialise its regenerative dry eye treatment, Elate Ocular, across Europe and the Middle East. This follows a second platelet-lysate licensing deal within days, underscoring growing industry confidence in Cambium’s platform.

Patriot Battery Metals has reached a significant milestone in the permitting process for its Shaakichiuwaanaan Lithium Project, with federal and provincial environmental assessments now aligned and progressing on schedule.

Cambium Bio has struck a licensing deal with Keke Medtech to commercialise its fibrin biologic in dental applications, unlocking new markets and non-dilutive funding.

Enova Mining has completed its first systematic geochemical sampling at the Santo Antônio do Jacinto project in Brazil, marking a significant step in exploring rare earth elements in a promising greenfield area. Assay results are expected by the end of September, setting the stage for targeted follow-up exploration.

Fat Prophets Global Contrarian Fund Ltd has reported a robust 56% increase in net profit for the year ended 30 June 2025, driven by strong investment returns and a leveraged global equity portfolio. The company also declared a fully franked special dividend, reflecting confidence in its ongoing performance.